|
|
| Vitamines - Compléments Alimentaires > Etude de marché sectorielle |
| OTC Healthcare in Greece to 2010 |
|
|
|
|
€ 396,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Février 2007 |
Taille du document : |
159 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
OTC Vitamins and Dietary Supplements in Germany
10 pages | Juin 2005 |
Euromonitor International’s ‘OTC Vitamins and Dietary Supplements in Germany' Major Market Profile report offers an introduction to the market.
It is c.
10 pages long and provides a top line ov |
198,00 €
|
| |
| |
Nutraceuticals in Germany
18 pages | Novembre 2004 |
Datamonitor's Nutraceuticals in Germany industry profile is an essential resource for top-level data and analysis covering the nutraceuticals industry.
It includes data on market size and segmentat |
160,00 €
|
| |
| |
US Mineral Supplements 2004
12 pages | Novembre 2004 |
Snapdata's US Mineral Supplements 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US mineral supplement mark |
240,00 €
|
| |
| |
Future Health Trends in Food and Drinks: Growth opportunities in daily dosing, GI, heart health, right fats and phood
196 pages | Août 2005 |
The GI diet is being driven due to rising obesity, rising diabetes and because the diet can be essentially seen as a sophistication of the Atkins diet; manufacturers are driving the trend by tailoring |
1 623,50 €
|
| |
| |
Herbal Supplements and Remedies
315 pages | Août 2006 |
This report analyzes the worldwide markets for Herbal Supplements and Remedies in Millions of US$.
The Major product segments analyzed are Ginkgo Biloba, Garlic, Ginseng, Echinacea, St.
John's W |
3 160,00 €
|
| |
| |
Herbal Supplements and Remedies
279 pages | Octobre 2005 |
This report analyzes the worldwide markets for Herbal Supplements and Remedies in Millions of US$.
Major product segments analyzed are Ginkgo Biloba, Garlic, Ginseng, Echinacea, St.
John's Wort, |
3 091,00 €
|
| |
| |
OTC Vitamins and Dietary Supplements in the United Kingdom
10 pages | Juin 2005 |
Euromonitor International’s ‘OTC Vitamins and Dietary Supplements in the UK' Major Market Profile report offers an introduction to the market.
It is c.
10 pages long and provides a top line ove |
198,00 €
|
| |
| |
Innovation in Natural and Organic Food and Drinks: Winning NPD strategies and future trends in healthy and ethical products
122 pages | Mai 2006 |
The terms natural and organic are not mutually exclusive: many products are marketed as ‘natural’ without organic certification; likewise, a number of organic products do not incorporate the term ‘nat |
1 528,00 €
|
| |
| |
Nutraceuticals in France
18 pages | Novembre 2004 |
Datamonitor's Nutraceuticals in France industry profile is an essential resource for top-level data and analysis covering the nutraceuticals industry.
It includes data on market size and segmentati |
160,00 €
|
| |
| |
UK Functional Foods
178 pages | Janvier 2007 |
Functional foods — i.e.
those that claim to have other health benefits in addition to their nutritional value — tend to be promoted mainly as being able to help prevent heart disease, digestive pro |
1 390,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| OTC Healthcare in Greece to 2010 |
|
|
Introduction
This databook is a detailed information resource covering all the key data points on OTC Healthcare in Greece. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2005 and full forecasts to 2010
Scope
Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products.Provides market value, volume, expenditure and consumption data by market, segment and subsegment.Includes company and brand share data by category, as well as distribution channel data.Contains market value segmentation by demographic and socioeconomic group.
Highlights
The market for OTC Healthcare in Greece increased between 2000-2005, growing at an average annual rate of 5.8%.
The leading company in the market in 2005 was Pfizer Inc. The second-largest player was Bristol-Myers Squibb Company with Korres Natural Products in third place.
Reasons to Purchase
Discover the major quantitative trends affecting the OTC Healthcare markets.Understand consumers' consumption and expenditure patterns.Understand the future direction of the market with reliable historical data and full five year forecasting.
|
|
TABLE OF CONTENTS
ABOUT DATAMONITOR 2
TABLE OF CONTENTS 3
LIST OF TABLES 7
LIST OF FIGURES 18
CHAPTER 1 INTRODUCTION 20
What is this report about? 20
How to use this report 20
Definitions 20
CHAPTER 2 GREECE OTC HEALTHCARE 25
2.1 Value 25
2.2 Market Share 33
2.3 Distribution 37
2.4 Expenditure & consumption per head 38
2.5 ConsumerGraphics 42
CHAPTER 3 GREECE ANALGESICS 45
3.1 Value 45
3.2 Market Share 50
3.3 Distribution 52
3.4 Expenditure & consumption per head 53
3.5 ConsumerGraphics 55
CHAPTER 4 GREECE COUGH AND COLD PREPARATIONS 58
4.1 Value 58
4.2 Market Share 64
4.3 Distribution 66
4.4 Expenditure & consumption per head 67
4.5 ConsumerGraphics 70
CHAPTER 5 GREECE INDIGESTION PREPARATIONS 73
5.1 Value 73
5.2 Market Share 78
5.3 Distribution 80
5.4 Expenditure & consumption per head 81
5.5 ConsumerGraphics 83
CHAPTER 6 GREECE MEDICATED SKIN PRODUCTS 86
6.1 Value 86
6.2 Market Share 92
6.3 Distribution 94
6.4 Expenditure & consumption per head 95
6.5 ConsumerGraphics 98
CHAPTER 7 GREECE TRADITIONAL MEDICINES 101
7.1 Value 101
7.2 Market Share 105
7.3 Distribution 107
7.4 Expenditure & consumption per head 108
7.5 ConsumerGraphics 110
CHAPTER 8 GREECE VITAMINS AND MINERALS 113
8.1 Value 113
8.2 Market Share 119
8.3 Distribution 121
8.4 Expenditure & consumption per head 122
8.5 ConsumerGraphics 124
CHAPTER 9 GREECE OTHER OTC HEALTHCARE 127
9.1 Value 127
9.2 Market Share 133
9.3 Distribution 137
9.4 Expenditure & consumption per head 138
9.5 ConsumerGraphics 141
CHAPTER 10 GREECE SOCIOECONOMIC PROFILE 144
10.1 Country Overview 144
10.2 Key Facts 145
10.3 Political Overview 146
10.4 Greece Economic Overview 147
CHAPTER 11 GREECE MACROECONOMIC PROFILE 148
11.1 Macroeconomic Indicators 148
CHAPTER 12 RESEARCH METHODOLOGY 154
12.1 Methodology overview 154
12.2 Secondary research 155
12.3 Market modelling 156
12.4 Primary research 157
12.5 Data finalisation 158
12.6 Ongoing research 158
CHAPTER 13 APPENDIX 159
13.1 Future readings 159
13.2 How to contact experts in your industry 159
LIST OF TABLES
Table 1: OTC Healthcare category definitions 21
Table 2: OTC Healthcare distribution channels 23
Table 3: Greece OTC Healthcare value, 2000-2005 (EUR m, 2005 prices) 25
Table 4: Greece OTC Healthcare value forecast, 2005-2010 (EUR m, 2005 prices) 26
Table 5: Greece OTC Healthcare value, 2000-2005 (EUR m, nominal prices) 28
Table 6: Greece OTC Healthcare value forecast, 2005-2010 (EUR m, nominal prices) 29
Table 7: Greece OTC Healthcare value, 2000-2005 (US$ m nominal prices) 30
Table 8: Greece OTC Healthcare value forecast, 2005-2010 (US$ m nominal prices) 31
Table 9: Greece OTC Healthcare brand share, by value, 2004-2005 (%) 33
Table 10: Greece OTC Healthcare value, by brand, 2004-2005 (EUR m nominal prices) 34
Table 11: Greece OTC Healthcare company share, by value, 2004-2005 (%) 35
Table 12: Greece OTC Healthcare value, by company, 2004-2005 (EUR m nominal prices) 36
Table 13: Greece OTC Healthcare distribution channels, by value, 2004-2005 (%) 37
Table 14: Greece OTC Healthcare value, by distribution channel, 2004-2005 (EUR m nominal prices) 37
Table 15: Greece OTC Healthcare expenditure per head, 2000-2005 (EUR, 2005 prices) 38
Table 16: Greece OTC Healthcare forecast expenditure per head, 2005-2010 (EUR, 2005 prices) 39
Table 17: Greece OTC Healthcare expenditure per head, 2000-2005 (US$ nominal prices) 40
Table 18: Greece OTC Healthcare forecast expenditure per head, 2005-2010 (US$ nominal prices) 41
Table 19: Greece OTC Healthcare value, by age group, 2005 42
Table 20: Greece OTC Healthcare value, by income group, 2005 42
Table 21: Greece OTC Healthcare value, by gender, 2005 43
Table 22: Greece OTC Healthcare value, by marital status, 2005 43
Table 23: Greece OTC Healthcare value, by size of household, 2005 43
Table 24: Greece OTC Healthcare value, by region, 2005 44
Table 25: Greece OTC Healthcare value, by urban/rural residence, 2005 44
Table 26: Greece Analgesics value, 2000-2005 (EUR m, 2005 prices) 45
Table 27: Greece Analgesics value forecast, 2005-2010 (EUR m, 2005 prices) 45
Table 28: Greece Analgesics value, 2000-2005 (EUR m, nominal prices) 47
Table 29: Greece Analgesics value forecast, 2005-2010 (EUR m, nominal prices) 47
Table 30: Greece Analgesics value, 2000-2005 (US$ m nominal prices) 48
Table 31: Greece Analgesics value forecast, 2005-2010 (US$ m nominal prices) 48
Table 32: Greece Analgesics brand share, by value, 2004-2005 (%) 50
Table 33: Greece Analgesics value, by brand, 2004-2005 (EUR m nominal prices) 50
Table 34: Greece Analgesics company share, by value, 2004-2005 (%) 51
Table 35: Greece Analgesics value, by company, 2004-2005 (EUR m nominal prices) 51
Table 36: Greece Analgesics distribution channels, by value, 2004-2005 (%) 52
Table 37: Greece Analgesics value, by distribution channel, 2004-2005 (EUR m nominal prices) 52
Table 38: Greece Analgesics expenditure per head, 2000-2005 (EUR, 2005 prices) 53
Table 39: Greece Analgesics forecast expenditure per head, 2005-2010 (EUR, 2005 prices) 53
Table 40: Greece Analgesics expenditure per head, 2000-2005 (US$ nominal prices) 54
Table 41: Greece Analgesics forecast expenditure per head, 2005-2010 (US$ nominal prices) 54
Table 42: Greece Analgesics, by age group, 2005 55
Table 43: Greece Analgesics, by income group, 2005 55
Table 44: Greece Analgesics, by gender, 2005 56
Table 45: Greece Analgesics, by marital status, 2005 56
Table 46: Greece Analgesics, by size of household, 2005 56
Table 47: Greece Analgesics, by region, 2005 57
Table 48: Greece Analgesics, by urban/rural residence, 2005 57
Table 49: Greece Cough and cold preparations value, 2000-2005 (EUR m, 2005 prices) 58
Table 50: Greece Cough and cold preparations value forecast, 2005-2010 (EUR m, 2005 prices) 59
Table 51: Greece Cough and cold preparations value, 2000-2005 (EUR m, nominal prices) 61
Table 52: Greece Cough and cold preparations value forecast, 2005-2010 (EUR m, nominal prices) 61
Table 53: Greece Cough and cold preparations value, 2000-2005 (US$ m nominal prices) 62
Table 54: Greece Cough and cold preparations value forecast, 2005-2010 (US$ m nominal prices) 62
Table 55: Greece Cough and cold preparations brand share, by value, 2004-2005 (%) 64
Table 56: Greece Cough and cold preparations value, by brand, 2004-2005 (EUR m nominal prices) 64
Table 57: Greece Cough and cold preparations company share, by value, 2004-2005 (%) 65
Table 58: Greece Cough and cold preparations value, by company, 2004-2005 (EUR m nominal prices) 65
Table 59: Greece Cough and cold preparations distribution channels, by value, 2004-2005 (%) 66
Table 60: Greece Cough and cold preparations value, by distribution channel, 2004-2005 (EUR m nominal prices) 66
Table 61: Greece Cough and cold preparations expenditure per head, 2000-2005 (EUR, 2005 prices) 67
Table 62: Greece Cough and cold preparations forecast expenditure per head, 2005-2010 (EUR, 2005 prices) 68
Table 63: Greece Cough and cold preparations expenditure per head, 2000-2005 (US$ nominal prices) 69
Table 64: Greece Cough and cold preparations forecast expenditure per head, 2005-2010 (US$ nominal prices) 69
Table 65: Greece Cough and cold preparations, by age group, 2005 70
Table 66: Greece Cough and cold preparations, by income group, 2005 70
Table 67: Greece Cough and cold preparations, by gender, 2005 71
Table 68: Greece Cough and cold preparations, by marital status, 2005 71
Table 69: Greece Cough and cold preparations, by size of household, 2005 71
Table 70: Greece Cough and cold preparations, by region, 2005 72
Table 71: Greece Cough and cold preparations, by urban/rural residence, 2005 72
Table 72: Greece Indigestion preparations value, 2000-2005 (EUR m, 2005 prices) 73
Table 73: Greece Indigestion preparations value forecast, 2005-2010 (EUR m, 2005 prices) 73
Table 74: Greece Indigestion preparations value, 2000-2005 (EUR m, nominal prices) 75
Table 75: Greece Indigestion preparations value forecast, 2005-2010 (EUR m, nominal prices) 75
Table 76: Greece Indigestion preparations value, 2000-2005 (US$ m nominal prices) 76
Table 77: Greece Indigestion preparations value forecast, 2005-2010 (US$ m nominal prices) 76
Table 78: Greece Indigestion preparations brand share, by value, 2004-2005 (%) 78
Table 79: Greece Indigestion preparations value, by brand, 2004-2005 (EUR m nominal prices) 78
Table 80: Greece Indigestion preparations company share, by value, 2004-2005 (%) 79
Table 81: Greece Indigestion preparations value, by company, 2004-2005 (EUR m nominal prices) 79
Table 82: Greece Indigestion preparations distribution channels, by value, 2004-2005 (%) 80
Table 83: Greece Indigestion preparations value, by distribution channel, 2004-2005 (EUR m nominal prices) 80
Table 84: Greece Indigestion preparations expenditure per head, 2000-2005 (EUR, 2005 prices) 81
Table 85: Greece Indigestion preparations forecast expenditure per head, 2005-2010 (EUR, 2005 prices) 81
Table 86: Greece Indigestion preparations expenditure per head, 2000-2005 (US$ nominal prices) 82
Table 87: Greece Indigestion preparations forecast expenditure per head, 2005-2010 (US$ nominal prices) 82
Table 88: Greece Indigestion preparations, by age group, 2005 83
Table 89: Greece Indigestion preparations, by income group, 2005 83
Table 90: Greece Indigestion preparations, by gender, 2005 84
Table 91: Greece Indigestion preparations, by marital status, 2005 84
Table 92: Greece Indigestion preparations, by size of household, 2005 84
Table 93: Greece Indigestion preparations, by region, 2005 85
Table 94: Greece Indigestion preparations, by urban/rural residence, 2005 85
Table 95: Greece Medicated skin products value, 2000-2005 (EUR m, 2005 prices) 86
Table 96: Greece Medicated skin products value forecast, 2005-2010 (EUR m, 2005 prices) 87
Table 97: Greece Medicated skin products value, 2000-2005 (EUR m, nominal prices) 89
Table 98: Greece Medicated skin products value forecast, 2005-2010 (EUR m, nominal prices) 89
Table 99: Greece Medicated skin products value, 2000-2005 (US$ m nominal prices) 90
Table 100: Greece Medicated skin products value forecast, 2005-2010 (US$ m nominal prices) 90
Table 101: Greece Medicated skin products brand share, by value, 2004-2005 (%) 92
Table 102: Greece Medicated skin products value, by brand, 2004-2005 (EUR m nominal prices) 92
Table 103: Greece Medicated skin products company share, by value, 2004-2005 (%) 93
Table 104: Greece Medicated skin products value, by company, 2004-2005 (EUR m nominal prices) 93
Table 105: Greece Medicated skin products distribution channels, by value, 2004-2005 (%) 94
Table 106: Greece Medicated skin products value, by distribution channel, 2004-2005 (EUR m nominal prices) 94
Table 107: Greece Medicated skin products expenditure per head, 2000-2005 (EUR, 2005 prices) 95
Table 108: Greece Medicated skin products forecast expenditure per head, 2005-2010 (EUR, 2005 prices) 96
Table 109: Greece Medicated skin products expenditure per head, 2000-2005 (US$ nominal prices) 97
Table 110: Greece Medicated skin products forecast expenditure per head, 2005-2010 (US$ nominal prices) 97
Table 111: Greece Medicated skin products, by age group, 2005 98
Table 112: Greece Medicated skin products, by income group, 2005 98
Table 113: Greece Medicated skin products, by gender, 2005 99
Table 114: Greece Medicated skin products, by marital status, 2005 99
Table 115: Greece Medicated skin products, by size of household, 2005 99
Table 116: Greece Medicated skin products, by region, 2005 100
Table 117: Greece Medicated skin products, by urban/rural residence, 2005 100
Table 118: Greece Traditional medicines value, 2000-2005 (EUR m, 2005 prices) 101
Table 119: Greece Traditional medicines value forecast, 2005-2010 (EUR m, 2005 prices) 101
Table 120: Greece Traditional medicines value, 2000-2005 (EUR m, nominal prices) 103
Table 121: Greece Traditional medicines value forecast, 2005-2010 (EUR m, nominal prices) 103
Table 122: Greece Traditional medicines value, 2000-2005 (US$ m nominal prices) 104
Table 123: Greece Traditional medicines value forecast, 2005-2010 (US$ m nominal prices) 104
Table 124: Greece Traditional medicines brand share, by value, 2004-2005 (%) 105
Table 125: Greece Traditional medicines value, by brand, 2004-2005 (EUR m nominal prices) 105
Table 126: Greece Traditional medicines company share, by value, 2004-2005 (%) 106
Table 127: Greece Traditional medicines value, by company, 2004-2005 (EUR m nominal prices) 106
Table 128: Greece Traditional medicines distribution channels, by value, 2004-2005 (%) 107
Table 129: Greece Traditional medicines value, by distribution channel, 2004-2005 (EUR m nominal price) 107
Table 130: Greece Traditional medicines expenditure per head, 2000-2005 (EUR, 2005 prices) 108
Table 131: Greece Traditional medicines forecast expenditure per head, 2005-2010 (EUR, 2005 prices) 108
Table 132: Greece Traditional medicines expenditure per head, 2000-2005 (US$ nominal prices) 109
Table 133: Greece Traditional medicines forecast expenditure per head, 2005-2010 (US$ nominal prices) 109
Table 134: Greece Traditional medicines, by age group, 2005 110
Table 135: Greece Traditional medicines, by income group, 2005 110
Table 136: Greece Traditional medicines, by gender, 2005 111
Table 137: Greece Traditional medicines, by marital status, 2005 111
Table 138: Greece Traditional medicines, by size of household, 2005 111
Table 139: Greece Traditional medicines, by region, 2005 112
Table 140: Greece Traditional medicines, by urban/rural residence, 2005 112
Table 141: Greece Vitamins and minerals value, 2000-2005 (EUR m, 2005 prices) 113
Table 142: Greece Vitamins and minerals value forecast, 2005-2010 (EUR m, 2005 prices) 114
Table 143: Greece Vitamins and minerals value, 2000-2005 (EUR m, nominal prices) 116
Table 144: Greece Vitamins and minerals value forecast, 2005-2010 (EUR m, nominal prices) 116
Table 145: Greece Vitamins and minerals value, 2000-2005 (US$ m nominal prices) 117
Table 146: Greece Vitamins and minerals value forecast, 2005-2010 (US$ m nominal prices) 117
Table 147: Greece Vitamins and minerals brand share, by value, 2004-2005 (%) 119
Table 148: Greece Vitamins and minerals value, by brand, 2004-2005 (EUR m nominal prices) 119
Table 149: Greece Vitamins and minerals company share, by value, 2004-2005 (%) 120
Table 150: Greece Vitamins and minerals value, by company, 2004-2005 (EUR m nominal prices) 120
Table 151: Greece Vitamins and minerals distribution channels, by value, 2004-2005 (%) 121
Table 152: Greece Vitamins and minerals value, by distribution channel, 2004-2005 (EUR m nominal price) 121
Table 153: Greece Vitamins and minerals expenditure per head, 2000-2005 (EUR, 2005 prices) 122
Table 154: Greece Vitamins and minerals forecast expenditure per head, 2005-2010 (EUR, 2005 prices) 122
Table 155: Greece Vitamins and minerals expenditure per head, 2000-2005 (US$ nominal prices) 123
Table 156: Greece Vitamins and minerals forecast expenditure per head, 2005-2010 (US$ nominal prices) 123
Table 157: Greece Vitamins and minerals, by age group, 2005 124
Table 158: Greece Vitamins and minerals, by income group, 2005 124
Table 159: Greece Vitamins and minerals, by gender, 2005 125
Table 160: Greece Vitamins and minerals, by marital status, 2005 125
Table 161: Greece Vitamins and minerals, by size of household, 2005 125
Table 162: Greece Vitamins and minerals, by region, 2005 126
Table 163: Greece Vitamins and minerals, by urban/rural residence, 2005 126
Table 164: Greece Other OTC healthcare value, 2000-2005 (EUR m, 2005 prices) 127
Table 165: Greece Other OTC healthcare value forecast, 2005-2010 (EUR m, 2005 prices) 128
Table 166: Greece Other OTC healthcare value, 2000-2005 (EUR m, nominal prices 130
Table 167: Greece Other OTC healthcare value forecast, 2005-2010 (EUR m, nominal prices) 130
Table 168: Greece Other OTC healthcare value, 2000-2005 (US$ m nominal prices) 131
Table 169: Greece Other OTC healthcare value forecast, 2005-2010 (US$ m nominal prices) 131
Table 170: Greece Other OTC healthcare brand share, by value, 2004-2005 (%) 133
Table 171: Greece Other OTC healthcare value, by brand, 2004-2005 (EUR m nominal prices) 134
Table 172: Greece Other OTC healthcare company share, by value, 2004-2005 (%) 135
Table 173: Greece Other OTC healthcare value, by company, 2004-2005 (EUR m nominal prices) 136
Table 174: Greece Other OTC healthcare distribution channels, by value, 2004-2005 (%) 137
Table 175: Greece Other OTC healthcare value, by distribution channel, 2004-2005 (EUR m nominal prices) 137
Table 176: Greece Other OTC healthcare expenditure per head, 2000-2005 (EUR, 2005 prices) 138
Table 177: Greece Other OTC healthcare forecast expenditure per head, 2005-2010 (EUR, 2005 prices) 139
Table 178: Greece Other OTC healthcare expenditure per head, 2000-2005 (US$ nominal prices) 140
Table 179: Greece Other OTC healthcare forecast expenditure per head, 2005-2010 (US$ nominal prices) 140
Table 180: Greece Other OTC healthcare , by age group, 2005 141
Table 181: Greece Other OTC healthcare , by income group, 2005 141
Table 182: Greece Other OTC healthcare , by gender, 2005 142
Table 183: Greece Other OTC healthcare , by marital status, 2005 142
Table 184: Greece Other OTC healthcare , by size of household, 2005 142
Table 185: Greece Other OTC healthcare , by region, 2005 143
Table 186: Greece Other OTC healthcare , by urban/rural residence, 2005 143
Table 187: Greece Key Facts 145
Table 188: Greece population, by age group, 2000-2005 (millions) 148
Table 189: Greece population forecast, by age group, 2005-2010 (millions) 149
Table 190: Greece population, by gender, 2000-2005 (millions) 149
Table 191: Greece population forecast, by gender, 2005-2010 (millions) 150
Table 192: Greece real GDP, 2000-2005 (EUR bn, 2005 prices) 150
Table 193: Greece real GDP forecast, 2005-2010 (EUR bn, 2005 prices) 150
Table 194: Greece nominal GDP, 2000-2005 (EUR bn, nominal prices) 151
Table 195: Greece nominal GDP forecast, 2005-2010 (EUR bn, nominal prices) 151
Table 196: Greece real GDP, 2000-2005 (US$ bn, 2005 prices) 151
Table 197: Greece real GDP forecast, 2005-2010 (US$ bn, 2005 prices) 152
Table 198: Greece consumer price index, 2000-2005 (2000=100) 152
Table 199: Greece consumer price index, 2005-2010 (2000=100) 152
Table 200: Greece exchange rate, 2000-2005 153
LIST OF FIGURES
Figure 1: Greece OTC Healthcare value & value forecast, 2000-2010 (EUR m, 2005 prices) 27
Figure 2: Greece OTC Healthcare category growth comparison, by value, 2000-2010 32
Figure 3: Greece Analgesics value & value forecast, 2000-2010 (EUR m, 2005 prices) 46
Figure 4: Greece Analgesics segment growth comparison, by value, 2000-2010 49
Figure 5: Greece Cough and cold preparations value & value forecast, 2000-2010 (EUR m, 2005 prices) 60
Figure 6: Greece Cough and cold preparations segment growth comparison, by value, 2000-2010 63
Figure 7: Greece Indigestion preparations value & value forecast, 2000-2010 (EUR m, 2005 prices) 74
Figure 8: Greece Indigestion preparations segment growth comparison, by value, 2000-2010 77
Figure 9: Greece Medicated skin products value & value forecast, 2000-2010 (EUR m, 2005 prices) 88
Figure 10: Greece Medicated skin products segment growth comparison, by value, 2000-2010 91
Figure 11: Greece Traditional medicines value & value forecast, 2000-2010 (EUR m, 2005 prices) 102
Figure 12: Greece Vitamins and minerals value & value forecast, 2000-2010 (EUR m, 2005 prices) 115
Figure 13: Greece Vitamins and minerals segment growth comparison, by value, 2000-2010 118
Figure 14: Greece Other OTC healthcare value & value forecast, 2000-2010 (EUR m, 2005 prices) 129
Figure 15: Greece Other OTC healthcare segment growth comparison, by value, 2000-2010 132
Figure 16: Map of Greece 145
Figure 17: Annual data review process 155
|
|
|
PPLSEN
|
|
|
|
|
